Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 7;10(7):289.
doi: 10.3390/jcdd10070289.

Cardiac Function and Serum Biomarkers throughout Staged Fontan Palliation: A Prospective Observational Study

Affiliations

Cardiac Function and Serum Biomarkers throughout Staged Fontan Palliation: A Prospective Observational Study

J P G van der Ven et al. J Cardiovasc Dev Dis. .

Abstract

Fontan patients undergo multiple cardiothoracic surgeries in childhood. Following these procedures, ventricular function is temporarily decreased, and recovers over months. This is presumably related to cardiopulmonary bypass, but this is incompletely understood. Throughout the Fontan palliation, cardiac function is also affected by volume unloading. We aimed to gain insight into the biological processes related to impaired ventricular function and recovery following Fontan palliations using a panel of biomarkers. Furthermore, we described changes in ventricular function across the Fontan palliation due to volume unloading. We performed a prospective multicenter observational study in patients undergoing partial (PCPC) or total cavo-pulmonary connection (TCPC). Patients underwent assessment-including echocardiography and blood sampling-before surgery (T1), at first follow-up (T2), and 1 year after their procedures (T3). Blood samples were analyzed using a biomarker panel (OLINK CVD-III). Ninety-two biomarkers were expressed as principal components (PC) to limit multiple statistical testing. We included 32 PCPC patients aged 7.2 [5.3-10.3] months, and 28 TCPC patients aged 2.7 [2.2-3.8] years. The single ventricular longitudinal strain (SV GLS) temporarily decreased for PCPC patients at T2 (-15.1 ± 5.6 (T1) to -13.5 ± 5.2 (T2) to -17.3 ± 4.5 (T3), p < 0.047 for all differences), but not following TCPC. The serum biomarkers were expressed as 4 PCs. PC1, including biomarkers of cell-cell adhesion, was not related to any patient characteristic. PC2, including biomarkers of superoxide anion regulation, increased at T2. PC3, including biomarkers of cardiovascular development, related to the stage of Fontan palliation. PC4 was of uncertain biological or clinical significance. No PC was found that related to ventricular performance. The SV GLS was temporarily diminished following PCPC, but not following TCPC. Several biomarkers were related to post-operative stress and adaptation to the PCPC or TCPC circulation, but none were related to the outcome.

Keywords: Fontan palliation; biomarkers; congenital heart disease; single ventricle.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Principal component analysis. (A): Principal component 2 scores increased at the early post-operative study time point (T2). (B): Principal component 3 scores differed across Fontan palliation stages. Colors are arbitrary and added for clarity. PCPC: partial cavo-pulmonary connection; TCPC: total cavo-pulmonary connection. * p < 0.05; ** p < 0.01; *** p < 0.001.

References

    1. van der Ven J., Bosch E.V.D., Bogers A.J., Helbing W.A. State of the art of the Fontan strategy for treatment of univentricular heart disease. F1000Research. 2018;7:935. doi: 10.12688/f1000research.13792.1. - DOI - PMC - PubMed
    1. Iyengar A.J., Winlaw D.S., Galati J.C., Celermajer D.S., Wheaton G.R., Gentles T.L., Grigg L.E., Weintraub R.G., Bullock A., Justo R.N., et al. Trends in Fontan surgery and risk factors for early adverse outcomes after Fontan surgery: The Australia and New Zealand Fontan Registry experience. J. Thorac. Cardiovasc. Surg. 2014;148:566–575. doi: 10.1016/j.jtcvs.2013.09.074. - DOI - PubMed
    1. Bartz P.J., Driscoll D.J., Dearani J.A., Puga F.J., Danielson G.K., O’Leary P.W., Earing M.G., Warnes C.A., Hodge D.O., Cetta F. Early and late results of the modified fontan operation for heterotaxy syndrome 30 years of experience in 142 patients. J. Am. Coll. Cardiol. 2006;48:2301–2305. doi: 10.1016/j.jacc.2006.07.053. - DOI - PubMed
    1. Hirsch J.C., Goldberg C., Bove E.L., Salehian S., Lee T., Ohye R.G., Devaney E.J. Fontan operation in the current era: A 15-year single institution experience. Ann. Surg. 2008;248:402–410. doi: 10.1097/SLA.0b013e3181858286. - DOI - PubMed
    1. Perdreau E., Seguela P.E., Jalal Z., Perdreau A., Mouton J.B., Nelson-Veniard M., Guillet E., Iriart X., Ouattara A., Roubertie F., et al. Postoperative assessment of left ventricular function by two-dimensional strain (speckle tracking) after paediatric cardiac surgery. Arch. Cardiovasc. Dis. 2016;109:599–606. doi: 10.1016/j.acvd.2016.03.005. - DOI - PubMed

Grants and funding